Cadrenal Therapeutics, Inc. (CIK: 0001937993) EDGAR, Information, Filings... CompaniesBIO.Com

Cadrenal Therapeutics, Inc.

Mailing address
822 A1A NORTH, SUITE 300, PONTE VEDRA, Delaware, 32082
Phone
904-300-0701
State location
Florida
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Cadrenal Therapeutics, Inc. (CIK: 0001937993) is an American company incorporated in the state of Florida. Head office is located at 822 A1A NORTH, SUITE 300, PONTE VEDRA, Florida, 32082. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Cadrenal Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Lisicki Robert	0001779614	Jul-23-2023	director
MURPHY JOHN RAYMOND	0001275195	Jan-19-2023	director
Szot Matthew K	0001401385	Jan-19-2023	officer: Chief Financial Officer
Pham Quang X	0001405290	Jan-19-2023	director, 10 percent owner, officer: CEO and Chairman
WILSON GLYNN	0001405625	Jan-19-2023	director
Zelenkofske Steven	0001578333	Jan-19-2023	director
LOSORDO DOUGLAS W	0001583810	Jan-19-2023	officer: Chief Medical Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Cadrenal Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001213900-24-076144 (34 Act) Size: KB	Sep-05-2024	001-41596 241282029
8-K	Document	Current report filing Acc-no: 0001213900-24-070883 (34 Act) Size: KB	Aug-20-2024	001-41596 241222529
8-K	Document	Current report filing Acc-no: 0001213900-24-069941 (34 Act) Size: KB	Aug-16-2024	001-41596 241214046
8-K	Document	Current report filing Acc-no: 0001213900-24-066613 (34 Act) Size: KB	Aug-08-2024	001-41596 241188184
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-066107 (34 Act) Size: KB	Aug-07-2024	001-41596 241183484
8-K	Document	Current report filing Acc-no: 0001213900-24-065400 (34 Act) Size: KB	Aug-06-2024	001-41596 241177421
8-K	Document	Current report filing Acc-no: 0001013762-24-003209 (34 Act) Size: KB	Jul-31-2024	001-41596 241161889
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001213900-24-052088 (34 Act) Size: KB	Jun-12-2024	001-41596 241038500
ARS	Document	Annual report to security holders Acc-no: 0001213900-24-051806 (34 Act) Size: KB	Jun-11-2024	001-41596 241036839
DEF 14A	Document	Definitive proxy statements Acc-no: 0001213900-24-051803 (34 Act) Size: KB	Jun-11-2024	001-41596 241036819
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001213900-24-047553 (34 Act) Size: KB	May-29-2024	001-41596 24999785
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-041014 (34 Act) Size: KB	May-09-2024	001-41596 24928389
8-K	Document	Current report filing Acc-no: 0001213900-24-040955 (34 Act) Size: KB	May-09-2024	001-41596 24927897
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-031923 ( Act) Size: 0 KB	Apr-10-2024
8-K	Document	Current report filing Acc-no: 0001213900-24-031371 (34 Act) Size: KB	Apr-09-2024	001-41596 24831382
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-029930 ( Act) Size: 0 KB	Apr-03-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001213900-24-029925 ( Act) Size: 0 KB	Apr-03-2024
EFFECT	Document	Acc-no: 9999999995-24-000826 (33 Act) Size: KB	Apr-02-2024	333-273384 24816753
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001213900-24-028970 (33 Act) Size: KB	Apr-02-2024	333-273384 24811446
EFFECT	Document	Acc-no: 9999999995-24-000694 (33 Act) Size: KB	Mar-20-2024	333-277835 24769291

Recent 20 filings. View all Cadrenal Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Cadrenal Therapeutics, Inc. overview
Cadrenal Therapeutics, Inc. job
Cadrenal Therapeutics, Inc. stock
Cadrenal Therapeutics, Inc. ownership
Cadrenal Therapeutics, Inc. CEO
Cadrenal Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.